Optimizing Haploidentical Donor Selection for Pediatric Hematopoietic Cell Transplant

Donors <18 years are associated with reduced aGVHD and cGVHD, whereas maternal donors are associated with increased cGVHD risk. For pediatric patients, sibling donors should be considered to reduce GVHD.